# A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors

> **NCT07050459** · PHASE1 · RECRUITING · sponsor: **Jiangsu Simcere Pharmaceutical Co., Ltd.** · enrollment: 220 (estimated)

## Conditions studied

- Locally Advanced Solid Tumors

## Interventions

- **DRUG:** SIM0686
- **DRUG:** SIM0686

## Key facts

- **NCT ID:** NCT07050459
- **Lead sponsor:** Jiangsu Simcere Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-20
- **Primary completion:** 2027-12
- **Final completion:** 2028-12
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07050459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07050459, "A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07050459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*